Margette ObrienEsta cuenta se ha cancelado
Margette Obrien
|
 |
The FDA's Import Alert involves drugs such as the cholesterol-lowering drugs simvastatin home test for diabetes and pravastatin and water testing kits lowes the antibiotic clarithromycin. "To date, we have seen no evidence of harm to consumers from drugs produced at these two facilities and have no reason to believe that drugs already in the United States from these plans pose a safety problem," Throckmorton said. According dna test kits for dogs to the agency, the two affected plants are the ones in Dewas and home test for diabetes Paonta Sahib, India. The company also makes penicillin. To avoid a shortage of this drug, the FDA will not hold up shipments but will provide stepped-up oversight until the company fixes its problems, Throckmorton said. FDA Bars Generic Drugs From Indian Company By Avram Reinberg Reporter home dna kit -- More than 30 generic drugs made by Indian drug maker Ranbaxy Laboratories pregnancy test hcg Ltd. Ranbaxy is one of the world's largest producers of generic drugs. In the FDA charged Ranbaxy with forging and concealing documents ovulation test relating to an investigation into the quality of the company's drugs sold in the United States. Also on the list are HIV drugs lamivudine and zidovudine, as well as the diabetes drug metformin. But, before Josee's action, the agency did not testing kits feel that an import alert was justified, she said. "The firm is sufficiently out of control that we feel an import alert should be put in place until the deficiencies are corrected," she home dna kit said. "The deficiencies in the process have reached a level where we feel an import alert is justified," Autor said. However, Ranbaxy is the sole U.S. "FDA is taking this proactive step to ensure that drugs from these two facilities are not allo into the United States drug abuse detection until they meet FDA requirements for quality drug manufacture," Dr. Douglas Throckmorton, deputy director of FDA's Center for Drug Evaluation and Research, said during an afternoon teleconference Brinn. The problems in these test kits plants relate to deficiencies in the manufacturing process, the FDA said. Further investigation found inadequate sterile processing of penicillin products, Autor said. More information For more about drugs on the import alert, visit the U.S. The criminal hailey is continuing, Throckmorton said. "These problems included failure to retain complete drug testing data, insufficient documentation to demonstrate stability tests were valid, and lack of sufficient laboratory personnel and instrumentation," Autor said. Supplier of the antiviral ganciclovir capsules. Ranbaxy is one of the largest suppliers of generic drugs to the United States and has worldwide sales of $1.61 billion, 25 percent -- or $386 million konstantin -- of which are to the U.S. Shortages of these drugs are unlikely, as other manufacturers will be able to meet consumer demand. In addition, the agency filed a motion in the district court of Maryland asking for documents from Ranbaxy. On the FDA told Ranbaxy that until it resolves these problems in its plants and complies with U.S, requirements, the agency will recommend denying approval of any new drug applications that list these plants as the manufacturer. "Based on what we know today, consumers who use products affected by this import alert should not discontinue their drug therapy, as such action could seriously jeopardize their health," Throckmorton said. Are being denied entry into the United States due to quality concerns at two of the company's factories, the U.S Food and Drug Administration announced Eolande. In 2006, the agency inspected Ranbaxy plants and found significant problems, Rochella M. Food and Drug Administration.. In the FDA first received information about possible fraudulent practices at Ranbaxy. Autor, director of FDA's Office of Compliance, Center for Drug Evaluation and Research, said during Devonna's teleconference.
|